This live web event has ended. Thank you for attending. 0 of 8 Sessions Available FEB 04 February 04, 2020 Tue 4:00 PM EST 1H Closed Marlene S. Williams, MD, FACC APR 01 April 01, 2020 Wed 7:00 PM EDT 1H Closed Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Marlene S. Williams, MD, FACC JUN 18 June 18, 2020 Thu 7:00 PM EDT 1H Closed Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Scott Cameron, MD, PhD JUN 30 June 30, 2020 Tue 7:00 PM EDT 1H Closed Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Schuyler Jones, MD, FACC JUL 22 July 22, 2020 Wed 2:00 PM EDT 1H Closed Marlene S. Williams, MD, FACC Rachel M. Bond, MD, FACC JUL 25 July 25, 2020 Sat 1:00 PM EDT 1H 30M Closed Schuyler Jones, MD, FACC Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA AUG 11 August 11, 2020 Tue 8:00 PM EDT 1H Closed Scott Cameron, MD, PhD Marlene S. Williams, MD, FACC AUG 29 August 29, 2020 Sat 1:00 PM EDT 1H 30M Closed Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Contributors Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA Associate Professor of MedicineDirector of Health Services ResearchDuke UniversityDurham, NCTracy Y. Wang, MD, MHS, MSc, FACC, FAHA is an Associate Professor of Medicine with Tenure in Cardiology at Duke University. An undergraduate of Yale University, she received her medical doctorate from Harvard Medical School and also holds an MSc degree in molecular biochemistry/biophysics from Yale University and an MHS degree in clinical research from Duke University. She joined the faculty at Duke University in 2008.Dr. Wang is a health services researcher with expertise in implementation science and pragmatic clinical trials. She has led several cardiovascular clinical trials and registries at the Duke Clinical Research Institute (DCRI) that have focused on comparative effectiveness and safety, health disparities, care quality assessment and quality improvement. To date, she has published more than 250 manuscripts on these topics. She was the Principal Investigator of the ARTEMIS randomized clinical trial studying the impact of copayment reduction on antiplatelet medication adherence and outcomes after myocardial infarction. She has lectured widely on the use of “big data” to identify treatment gaps for intervention and has led projects using data solutions to design and implement quality-improvement initiatives. In addition, she is interested in evolving the platform for research to improve site and patient recruitment, innovate longitudinal patient follow-up, enrich the collection of patient-reported outcomes, pragmatically adjudicate clinical events of interest, and add important health economic insights.Dr. Wang chaired the American Heart Association’s Quality of Care and Outcomes Research Council from 2017-2019, and serves on many task forces, committees, and writing groups for the American Heart Association, American College of Cardiology, and American College of Physicians. She is an Associate Editor of the JAMA Internal Medicine journal. She is the Director of Health Services and Outcomes Research at the DCRI and remains a practicing noninvasive cardiologist with both inpatient and outpatient responsibilities. Marlene S. Williams, MD, FACC Director, Cardiac Intensive Care UnitJohns Hopkins Bayview Medical CenterAssociate Professor of MedicineDivision of CardiologyJohns Hopkins UniversityBaltimore, MDMarlene S. Williams, MD, FACC is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research centers on coronary atherosclerosis and platelet function, and her particular focus is on platelet function as it relates to the acute coronary syndrome. Dr. Williams has examined platelet function and its correlation to platelet functional genomics and runs a platelet physiology laboratory on the Johns Hopkins Bayview campus. The goal for her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may improve this dysfunction and eventually be translated to therapies for patients with cardiovascular disease.She was the recipient of a National Institutes of Health (NIH) Career Mentored Award (K23) examining platelet functional genomics and an NIH RO1 Award addressing platelet serotonin signaling in depression and heart disease. Dr. Williams has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, and heart disease and depression. She has participated in several National Heart, Lung, and Blood Institute (NHLBI) advisory committees, review groups, and study sections.Dr. Williams received her undergraduate degree in biochemistry from McGill University. She earned a medical degree from the Columbia University College of Physicians and Surgeons and completed a residency at Johns Hopkins Hospital. Dr. Williams was a cardiology fellow at Mount Sinai Hospital and Johns Hopkins Hospital and is currently Director of the Cardiac Intensive Care Unit at Johns Hopkins Bayview Medical Center. Scott Cameron, MD, PhD Associate Director of Research in Vascular Medicine Staff Cardiologist and Assistant Professor of Medicine Cleveland Clinic Lerner College of Medicine Cleveland, OH Scott Cameron, MD, PhD, is a specialist in blood vessel disorders and platelet dysfunction in the Section of Vascular Medicine of the Tomsich Family Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute of the Cleveland Clinic. Dr. Cameron is an expert in management of vascular disease and also is experienced in caring for critically ill patients hospitalized with thrombotic emergencies, including heart attack, pulmonary embolism, aortic dissection, decompensated heart failure, complex arrhythmias, mechanical assistance and acute valvular pathology. He has performed or interpreted thousands of coronary angiograms, electrocardiograms, nuclear cardiology scans and noninvasive ultrasound studies. Dr. Cameron currently is Principal Investigator (PI) on a National Institutes of Health-funded study on cardiovascular complications that develop after heart attack and co-PI on an American Heart Association study related to the development of new treatments for stroke. He has been PI or co-PI on multiple basic, translational and clinical research studies on heart attack, arterial disease and aneurysm. Dr. Cameron has coauthored dozens of scientific papers and editorials in peer-reviewed medical journals on platelet disorders and vascular medicine and has been an invited lecturer at numerous international and national medical meetings and conferences. Dr. Cameron is also a Fellow of the American College of Cardiology and the Society of Vascular Medicine. He sits on various counsels of the American Heart Association. He is a peer reviewer for multiple medical journals including the British Medical Journal, the American Journal of Medicine, Annals of Internal Medicine, Circulation, Circulation Research, and the Journal of Thrombosis and Thrombolysis. He is also on the Editorial Board of ATVB, and he is an Associate Editor of Vascular Medicine. Schuyler Jones, MD, FACC Associate Professor of Medicine Director, Adult Cardiac Catheterization Laboratories Duke University Health System Durham, NCSchuyler Jones, MD, FACC is an interventional cardiologist and Associate Professor of Medicine in the Division of Cardiology at Duke University Medical Center, and his clinical interests include peripheral artery disease, coronary artery disease, and percutaneous coronary intervention. He currently serves as the Medical Director of the Duke Adult Cardiac Catheterization Laboratory and the medical director of the Duke Heart Center Clinical Research Unit (that oversees site-based research within the Heart Center). Since joining the Duke Faculty in 2010, Dr. Jones has worked as an investigator at the Duke Clinical Research Institute where he has been part of the leadership team for several clinical trials across a broad spectrum of cardiovascular care, including CAD, PAD, PCI, and CABG. He serves as the Co-Medical Director of the Clinical Endpoints Committee (CEC) at the DCRI, and has been an active participant in the angiographic core laboratory at DCRI. Recently, he has joined the Duke CTSA Recruitment Innovation Center as a co-Director. He has also been funded by the American Heart Association and the Doris Duke Charitable Foundation to investigate factors associated with the use and outcomes of patients with peripheral artery disease and peripheral vascular intervention. Currently, he is a co-principal investigator of the PCORI-funded demonstration project called Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study which is enrolling 15,000 patients with established cardiovascular disease at 40 clinical sites within PCORnet. Rachel M. Bond, MD, FACC System Director, Women's Heart HealthDignity Health, ArizonaAssistant Professor, Internal Medicine Division of Cardiovascular DiseaseCreighton University School of MedicineChandler, AZRachel M. Bond, MD, FACC is a board-certified attending cardiologist who has devoted her career to the treatment of heart disease through early detection, education, and prevention. She is the system-wide Medical Director of Women’s Heart Health at Dignity Health, in Arizona. Dr. Bond is the Co-chair of the Women in Cardiology Committee, as well as Chair of the Diversity and Inclusion Committee for the Arizona Chapter of the American College of Cardiology. She holds a faculty position as Assistant Professor of Internal Medicine at Creighton University School of Medicine. She sits on the leadership council of the Women in Cardiology section of the American College of Cardiology nationally. Dr. Bond earned a bachelor of science degree from the seven-year accelerated medical program at the Sophie Davis School of Biomedical Education, where she graduated Summa Cum Laude and earned her medical doctorate from NYU School of Medicine. She completed her training in internal medicine at NYU School of Medicine and in cardiovascular disease at Hofstra Northwell School of Medicine at North Shore University Hospital and Long Island Jewish Medical Center in New York. Dr. Bond is the author of several review papers referencing sex and gender differences and cardiovascular conditions that predominantly affect women, along with opinion pieces aimed at addressing health equity, reducing health disparities, and promoting the professional development of women and minorities in the health-science profession. She has a passion for advocacy of education and mentorship and has advised as an expert source through news and media outlets. Her clinical interests include heart-disease prevention, the non-invasive evaluation and treatment of heart disease, pregnancy-related heart conditions, and cardio-oncology and lipid disorders. Her research interests currently include the heart-mind connection and cardio-rheumatology. Dr. Bond is a Fellow of the American College of Cardiology and a member of the American Society for Preventive Cardiology, Association of Black Cardiologists, and the American Heart Association, where she is a national spokesperson for the “Go Red for Women” campaign and sits on the board of directors.